Colorado Democratic Rep. Diana DeGette, who lost her primary, was knowledgeable about biopharma, if not always a friend to the industry.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | STAT+: U.S. judge blocks Colorado’s first-of-its-kind price cap on an Amgen drug | 0 | 5 | 02-07-2026 |
| 2 | STAT+: A year after distressed buyout, what’s become of Bluebird Bio? | 0 | 5 | 02-07-2026 |
| 3 | Senate Days Are Numbered for Top Republican Charged With Ed. Dept. Oversight | 0 | 5 | 18-05-2026 |
| 4 | STAT+: Lawmakers urge HHS to force Eli Lilly to provide 340B drug discounts to hospitals | 0 | 5 | 02-07-2026 |
| 5 | Darializa Avila Chevalier upsets Rep. Adriano Espaillat | 0 | 5 | 24-06-2026 |
| 6 | STAT+: Up and down the ladder: The latest comings and goings | 0 | 2 | 02-07-2026 |
| 7 | Mamdani ally Claire Valdez captures congressional seat | 0 | 5 | 24-06-2026 |
| 8 | STAT+: A ‘historic’ FDA clearance raises the question: Is the LLM an interface or the decision-maker? | 0 | 5 | 02-07-2026 |
| 9 | What will dictate Reid Detmers’ status as a big MLB trade deadline target | 0 | 5 | 02-07-2026 |
| 10 | Kean's depression disclosure prompts questions about mental health stigma | 0 | 7 | 04-07-2026 |